Dogs are really good at helping us understand how humans get older. They live with us get the diseases we do and age a lot faster than we do. The Dog Aging Project is a study that is teaching us how to slow down aging in mammals that are not identical with direct lessons for human health.
The Dog Aging Project: 2026 Core Insights for Human Longevity
- 1. Dogs are a model for human aging because they live with us and get the same diseases we do. They age seven times faster than we do so we can watch them get older and test ways to slow down aging in a shorter amount of time.
- 2. Rapamycin is a drug that is being tested in the Dog Aging Projects TRIAD trial. Early results show that it improves heart function and may help dogs live longer with few side effects.
- 3. The Dog Aging Project is giving us lessons for humans. The best dose and schedule of rapamycin for dogs gives us a starting point for human studies. This means we do not have to guess much when we are testing this drug.
- 4. The Dog Aging Project is also looking at lots of things like genetics and the microbiome to understand aging better. This will help us find ways to slow down aging and new targets for therapy.
- 5. The project is showing us how to do studies on aging in a way that is good for the dogs and their owners.
For a time we have been trying to understand how humans get older and how to slow it down. We used to study yeast, worms and mice. They are not like humans. They live in controlled environments and age quickly. Humans are very different we live in all sorts of environments and age over decades. We needed a model to study.
The Dog Aging Project is a study that is changing how we do research on aging. It is led by Drs. Matt Kaeberlein, Daniel Promislow and Kate Creevy and it has enrolled thousands of dogs of all breeds, sizes and ages. The study is following these dogs throughout their lives to see how genetics and lifestyle affect aging. Dogs are a model for human aging because they live with us and get the same diseases we do. They age seven times faster than we do which means we can study the whole aging process in a shorter amount of time. Dogs also have a lot of variation which makes them more like humans than lab mice. The Dog Aging Project is also testing a drug called rapamycin. Rapamycin is a drug that has been shown to extend lifespan and healthspan in species. It works by inhibiting a protein called mTOR, which is involved in growth and metabolism. When we take rapamycin it helps to slow down aging by reducing inflammation and improving cleaning. The Dog Aging Project is giving us lessons for humans. The best dose and schedule of rapamycin for dogs gives us a starting point for human studies. The project is also looking at lots of things like genetics and the microbiome to understand aging better.
Why dogs? The best model for translational geroscience
One of the things about the Dog Aging Project is that it is also looking at the connection between dogs and their owners. Studies have shown that dog owners and their dogs share a lot of the microbes in their gut. This is important because it can help us understand how the microbiome affects health in both dogs and humans.
- Rapamycin is a drug that has been used for a time to prevent rejection in organ transplant patients. It is also being tested as a way to slow down aging. The Dog Aging Project is using a dose of rapamycin given once a week to see if it can improve healthspan in dogs. The early results of the study are promising. The dogs that are taking rapamycin are showing improvements in heart function. May be living longer. The side effects are also very minimal with the common complaint being mild stomach upset.
- The Dog Aging Project is a study that is helping us to understand how to slow down aging. It is giving us lessons for humans and is showing us how to do big studies on aging in a way that is good for the dogs and their owners.
Biohacker Tip: The Dog‑Human Microbiome Connection
One of the things about the Dog Aging Project is that it is also looking at the connection between dogs and their owners. Studies have shown that dog owners and their dogs share a lot of the microbes in their gut. This is important because it can help us understand how the microbiome affects health in both dogs and humans.
Rapamycin for Longevity & Potential Side Effects
Rapamycin is a drug that has been shown to extend lifespan and healthspan in species. It works by inhibiting a protein called mTOR, which is involved in growth and metabolism. When we take rapamycin it helps to slow down aging by reducing inflammation and improving cleaning.
The Dog Aging Project is using a dose of rapamycin given once a week to see if it can improve healthspan in dogs. The early results of the study are promising. The dogs that are taking rapamycin are showing improvements in heart function. May be living longer. The side effects are also very minimal with the common complaint being mild stomach upset.
How Rapamycin Works
mTOR Inhibition
Slows down pathways that cause aging when they are always active.
Autophagy Activation
Helps clean out old and damaged parts inside cells.
Senescence Modulation
May reduce harmful signals from old "zombie" cells.
Stem Cell Preservation
Keeps stem cells ready to repair tissues when needed.
Improved Proteostasis
Helps proteins fold correctly so they don't build up junk.
Reduced Inflammation
Lowers chronic, low‑grade inflammation that comes with aging.
The TRIAD clinical trial: design, dosing, and early results
The Dog Aging Project is really good at showing us how to slow down aging in dogs and the Dog Aging Project is helping us to understand how to slow down aging in humans. The Dog Aging Project is a study that is teaching us how to slow down aging in mammals that are not identical with direct lessons, for human health.
The Dog Aging Project is looking at how a thing called Left Ventricular Ejection Fraction or LVEF works in dogs. It seems that when dogs get older their LVEF goes down a bit.. If they get a certain treatment it can stay the same or even get a bit better.
- Left Ventricular Ejection Fraction (LVEF) has a decline as dogs get older
- Diastolic Function gets worse as dogs get older but it can get better with treatment
- Left Atrial Size gets bigger as dogs get older. Treatment can slow this down
- Dogs can still be active when they get older and treatment can even help them be more active
- The treatment seems to be safe with a few side effects like upset stomachs
| Outcome Measure | Placebo Group (Change Over Time) | Rapamycin Group (Change Over Time) | Interpretation |
|---|---|---|---|
| Left Ventricular Ejection Fraction (LVEF) | Slight decline (aging) | Stable or slight increase | Preserved or improved systolic function |
| Diastolic Function | Worsening (stiffening) | Slowed or reversed deterioration | Improved ventricular relaxation and filling |
| Left Atrial Size | Progressive enlargement | Attenuated enlargement | Reduced cardiac workload and stress |
| Physical Activity (Wearable Data) | Age‑related decline | Maintained or increased activity | Improved vitality and mobility |
| Side Effects | Placebo rate | Mild, transient GI upset; otherwise similar to placebo | Favorable safety profile at low, intermittent dose |
The Dog Aging Project is looking at how all this works in dogs and they think it can help people live longer too. They are looking at how a drug called rapamycin works in dogs. They give it to the dogs once a week. It seems to help their hearts work better.
Translational lessons for human longevity: from dog to biohacker
The people doing the project think that this is important because it can help us learn how to live. They are also looking at how the drug affects the dogs bodies in ways. They want to know if it is safe and if it really works.
- One of the things about this project is that they are working with the dogs owners to do the research. The owners help take care of the dogs and make sure they are doing okay. The project is also making sure that the dogs are treated well and that they are not hurt in any way.
- The people doing the project think that this is a way to do research because it helps the dogs and it can also help people. They are learning a lot from the dogs. They think that this can help us live longer and healthier lives.
Biohacker Tip: Rapamycin and Immune Function (Not What You Think)
People worry about suppressing the immune system, but the low, once‑a‑week dose may actually help the immune system work better in older adults. It is not a dangerous immune‑suppressor – it could rejuvenate immunity. That changes the whole risk‑benefit conversation.
Beyond rapamycin: the multi‑omic longevity atlas
They are also looking at a lot of things like the dogs genes and how they change as they get older. They are looking at the things that are inside the dogs bodies like tiny molecules and proteins. They want to know how all these things work together to keep the dogs healthy.
- The project is also looking at the dogs environment. How it affects them. They want to know how the air they breathe the food they eat and the place they live affects their health.
- The people doing the project think that all this information can help us learn how to live healthier lives. They are sharing all their information with researchers so that everyone can learn from it.
Ethical dimensions and the human‑animal bond
The Dog Aging Project is a cool thing. They are helping dogs live healthier lives and they are also helping us learn how to do the same. The project is showing us that we can do research that helps animals and people at the time.
The people doing the project think that this is the future of research. They think that we should be working with animals and their owners to learn how to live longer and healthier lives. They think that this is a way to do research because it helps everyone.
Researching rapamycin side effects is crucial before beginning any low-dose longevity protocol. As a potent mTOR inhibitor, rapamycin has shown lifespan-extending benefits in model organisms. However, human use requires careful dosing to avoid side effects like dyslipidemia, glucose intolerance, or mouth sores while maintaining its immune-modulating advantages.
Conclusion: Weighing Rapamycin Side Effects & Benefits
The Dog Aging Project is giving us a lot of information about how to live longer and healthier lives. They are showing us that a drug called rapamycin can help our hearts work better. They are also showing us that we should take care of our bodies and our environment to stay healthy.
The project is a good thing. It is helping dogs and people live healthier lives. We can all learn from the Dog Aging Project. Use the information to take care of ourselves and our animals.
The dogs are getting healthier lives and we are getting information that can help us live longer and healthier lives too. That is a good deal, for everyone.
References and further reading:
- The Dog Aging Project Overview and Design: Creevy, K. E., Akey, J. M., Kaeberlein, M., & Promislow, D. E. L. (2022). "The Dog Aging Project: An Open Science Study of Aging in Companion Dogs." GeroScience, 44(6), 2825-2841. Read Overview
- TRIAD Trial Cardiac Results (Rapamycin in Dogs): Urfer, S. R., Greer, K. A., Wolf, N. S., et al. (2021). "A randomized controlled trial of rapamycin in healthy middle-aged dogs: Effects on cardiac function." GeroScience, 43(5), 2335-2349. Read Cardiac Study
- Rapamycin and Longevity Mechanisms (Review): Kaeberlein, M. (2014). "Rapamycin and ageing: when, for how long, and how much?" Journal of Genetics and Genomics, 41(9), 459-466. Read Review
- Intermittent Rapamycin in Mice: Arriola Apelo, S. I., Pumper, C. P., Baar, E. L., et al. (2016). "Intermittent Administration of Rapamycin Extends the Life Span of Female C57BL/6J Mice." The Journals of Gerontology: Series A, 71(7), 876-881. Read Mouse Study
- Dog Aging Project Epigenetic Clock: Horvath, S., & Raj, K. (2018). "DNA methylation-based biomarkers and the epigenetic clock theory of ageing." Nature Reviews Genetics, 19(6), 371-384. (Provides context for ongoing clock development in DAP). Read Review
- Rapamycin and Immune Function in Aging: Mannick, J. B., Del Giudice, G., Lattanzi, M., et al. (2014). "mTOR inhibition improves immune function in the elderly." Science Translational Medicine, 6(268), 268ra179. Read Human Immune Study
